Synonyms: Emflaza® | MDL 458
deflazacort is an approved drug (UK (1994), FDA (2017))
Compound class:
Synthetic organic
Comment: Deflazacort is a prednisolone derivative glucocorticoid that is used as an anti-inflammatory and immunosuppressant. It is a prodrug that is metabolised to the active form, 21-desacetyl deflazacort (PubChem CID 97547130) [3].
![]() View more information in the IUPHAR Pharmacology Education Project: deflazacort |
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes (UK (1994), FDA (2017)) |
Approved drug? | Yes. UK (1994) | FDA (2017) |
Synonyms ![]() |
Emflaza® | MDL 458 |
Database Links ![]() |
|
DrugCentral Ligand | 793 |
GtoPdb PubChem SID | 329968417 |
PubChem CID | 189821 |
Search Google for chemical match using the InChIKey | FBHSPRKOSMHSIF-GRMWVWQJSA-N |
Search Google for chemicals with the same backbone | FBHSPRKOSMHSIF |
UniChem Compound Search for chemical match using the InChIKey | FBHSPRKOSMHSIF-GRMWVWQJSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | FBHSPRKOSMHSIF-GRMWVWQJSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Deflazacort (links to external site)
Cat. No. HY-13609 |